Organ allocation: model for end-stage liver disease, Child-Turcotte-Pugh, Mayo risk score, or something else

Area of Science:

• Hepatology
• Clinical Biochemistry
• Medical Prognostics

Background:

• The liver's complex functions have historically hindered the development of a single comprehensive liver function test.
• Current practice involves using liver test profiles, combining multiple individual tests.

Purpose of the Study:

• To present evidence supporting the combination of clinical and laboratory measures for predicting liver disease patient prognosis.
• To evaluate the utility and limitations of existing prognostic models like end-stage liver disease (ESLD) and pediatric end-stage liver disease (pEDL) models.

Main Methods:

• Review and synthesis of existing evidence on liver function testing and disease prognosis.
• Analysis of the predictive capabilities of combined clinical and laboratory measures.
• Assessment of the applicability of ESLD and pEDL models in diverse liver disease scenarios.

Main Results:

• Evidence confirms that combining multiple clinical and laboratory measures is essential for accurate liver disease prognosis.
• Existing models like ESLD and pEDL are valuable but have limitations.
• Some critical indications for liver transplantation, not solely based on disease severity, are not fully addressed by current models.

Conclusions:

• Accurate prediction of liver disease prognosis necessitates a multifaceted approach, integrating various clinical and laboratory data.
• While advanced models exist, they do not encompass all prognostic factors, particularly for conditions where severity is not the primary transplant indication.
• Further research is needed to develop comprehensive prognostic tools that address the full spectrum of liver disease and transplant eligibility.